- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03866785
Physical Activity Experiment on Male Prostate Cancer Patients (ACTI_PAIR)
Physical Activity Experiment on Male Prostate Cancer Patients : Feasibility Multicenter Study of an Innovative Follow-up by Peers
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: David HUPIN, MD
- Phone Number: +33 (0)477127985
- Email: david.hupin@chu-st-etienne.fr
Study Contact Backup
- Name: Amandine BAUDOT, CRA
- Phone Number: +33 (0)477120285
- Email: amandine.baudot@chu-st-etienne.fr
Study Locations
-
-
-
Saint-Priest-en-Jarez, France
- ICLN - département de radiothérapie
-
Saint-Priest-en-Jarez, France
- ICLN - Oncologie médicale
-
Saint-Étienne, France
- Chu Saint-Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for patient in step1, 2 and 3:
Major patient followed for prostate cancer:
- located or locally advanced,
- metastatic and / or resistant to castration and chemotherapy.
- Cancer diagnosed at least 1 year ago
- Patient affiliated or beneficiary to social security
- Signed informed consent.
In more, step 2 = Patient with Physical Activity for at least 1 year
Exclusion Criteria:
For step 1= In the course of cancer treatment (excluding hormonal therapy)
For step 2= Patient in sedentary lifestyle
For step 3=
- In the course of cancer treatment (excluding hormonal therapy)
- Cardiac or respiratory conditions contraindicating physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: STEP 1: Patient with prostate cancer
First, patients with prostate cancer will be included during step 1.
They will have an interview.
|
The goal is to evaluate the needs, the constraints and representations of patients on the practice of physical activity.
|
OTHER: STEP 2: Patient with prostate cancer and a physical activity
Secondly, patient with prostate cancer and a physical activity will be included during step 2. They are called "peer". They will have a questionnaire Adult Physical Activity Questionnaire (APAQ), an activity actigraph and a peer training. The peer will help patients to realize the Physical Activity Program during step 3. |
The goal of this questionnaire is to evaluate the sedentary lifestyle of patients.
An activity actigraph will use by the patient for a week.
It measures the level of physical activity and the sedentary lifestyle of patients.
The goal of the peer training will organize once a week for 3 weeks for a patient. After this training, they will have :
|
OTHER: STEP 3: Physical Activity Program
Finally, patients with prostate cancer (different from step 1) and who agrees to participate at the Physical Activity Program will be included during step 3. They will have an activity actigraph and a questionnaire Adult Physical Activity Questionnaire (APAQ) at inclusion and 3 months later. They will receive the Physical Activity Program. |
The goal of this questionnaire is to evaluate the sedentary lifestyle of patients.
An activity actigraph will use by the patient for a week.
It measures the level of physical activity and the sedentary lifestyle of patients.
During the Physical Activity Program, patients will be supervised by peers and a clubs and sports associations labeled sport-health by Olympic and Sports Committee of the Loire Department. The peer will coach the patient once a week minimum for 3 months. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity sessions performed
Time Frame: At month 3
|
Analysis of the proportion (%) of Physical Activity sessions performed after 3 months of intervention.
|
At month 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
physical activity via activity actigraph
Time Frame: At month 3
|
Assessment of physical activity via activity actigraph
|
At month 3
|
sedentary lifestyle via activity actigraph
Time Frame: At month 3
|
Assessment of sedentary lifestyle via activity actigraph
|
At month 3
|
Patient's activation
Time Frame: At month 3
|
Measure patient's activation via questionnaire Patient Activation Measure (PAM).
|
At month 3
|
brakes blocking intervention
Time Frame: At month 3
|
Identification of brakes blocking intervention via interviews and Adult Physical Activity Questionnaire (APAQ).
APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day)
|
At month 3
|
levers favoring intervention
Time Frame: At month 3
|
Identification of levers favoring intervention via interviews and Adult Physical Activity Questionnaire (APAQ).
APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day)
|
At month 3
|
Peers mobilized
Time Frame: At month 3
|
Number of peers mobilized
|
At month 3
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18CH034
- 2018-A00710-55 (OTHER: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Prostate
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on interview
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
Ohio UniversityNew York Blood CenterCompleted
-
University of New MexicoCompletedPregnancy TerminationUnited States
-
Centro Hospitalar Lisboa NorteUniversity of Lisbon; Faculdade de Psicologia e de Ciências de Educação da...Unknown
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceCompletedCancer | Elderly | Ethnographic Interview | Social Representation of Being Aged | Reasons of Non-participation in Clinical Trials | Qualitative MethodFrance
-
Dongzhimen Hospital, BeijingUnknown
-
University of Eastern FinlandCompleted
-
Beth Israel Deaconess Medical CenterCompletedDyspepsia | Heartburn | Gastroesophageal Reflux Disease (GERD)United States
-
University Hospital, GrenobleRegional Council of Auvergne-Rhône-AlpesRecruitingTraumatic Brain InjuryFrance